Is NRx Pharmaceuticals, Inc. overvalued?

NRx Pharmaceuticals, Inc. (NRXP) — key valuation metrics and fundamentals.

No verdict

Price

$2.87

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$49.6M

Dividend yield

0.0%

Return on equity

168.7%

Sector

Healthcare

Fair value compares NRXP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks